The Food and Drugs Authority Ghana and Rwanda last week signed a #Memorandum of Understanding (MoU) for regulatory collaboration.
The two agencies will collaborate in providing vaccine manufacture regulatory oversight, and to fulfil the regulatory requirements for the #BioNTech vaccines that will be manufactured in #Rwanda and filled-and-finished in #Ghana.
The Ghana FDA, will also support the Rwanda FDA to attain WHO Global Benchmarking Maturity Level 3 (WHO ML 3).
This MoU is timely as the two countries have established collaboration for the first Pan-African end-to-end mRNA vaccine manufacturing in Africa. The close collaboration between the regulators will help ensure the safety, quality and efficacy of the mRNA vaccines that will be manufactured. Effective regulation is a key pillar for the success of this Pan-African initiative.
GIZ, with funding from the Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung (BMZ) and the EU, is providing support to further strengthen the Ghana FDA, which is already at WHO ML 3, to attain WHO ML 4 status.
